Annual Current Assets
N/A
December 1, 2024
Summary
- PFE annual total current assets is not available.
Performance
PFE Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Assets
N/A
December 1, 2024
Summary
- PFE quarterly total current assets is not available.
Performance
PFE Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
PFE Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PFE Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Pfizer Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $43.22 B(+14.3%) |
| Jun 2024 | - | $37.83 B(-10.8%) |
| Mar 2024 | - | $42.41 B(-2.1%) |
| Dec 2023 | $183.17 B(+25.5%) | $43.33 B(-41.5%) |
| Sep 2023 | - | $74.01 B(+0.9%) |
| Jun 2023 | - | $73.35 B(+46.5%) |
| Mar 2023 | - | $50.08 B(-2.3%) |
| Dec 2022 | $145.94 B(+19.8%) | $51.26 B(-27.2%) |
| Sep 2022 | - | $70.40 B(+4.4%) |
| Jun 2022 | - | $67.47 B(+24.0%) |
| Mar 2022 | - | $54.42 B(-8.8%) |
| Dec 2021 | $121.78 B(+2.2%) | $59.69 B(+3.1%) |
| Sep 2021 | - | $57.90 B(+18.6%) |
| Jun 2021 | - | $48.81 B(+23.5%) |
| Mar 2021 | - | $39.53 B(+12.7%) |
| Dec 2020 | $119.16 B(-11.6%) | $35.07 B(-26.5%) |
| Sep 2020 | - | $47.74 B(+2.8%) |
| Jun 2020 | - | $46.42 B(+33.6%) |
| Mar 2020 | - | $34.74 B(+5.9%) |
| Dec 2019 | $134.79 B(+23.1%) | $32.80 B(-2.0%) |
| Sep 2019 | - | $33.46 B(-28.9%) |
| Jun 2019 | - | $47.07 B(+3.9%) |
| Mar 2019 | - | $45.29 B(-9.3%) |
| Dec 2018 | $109.50 B(-16.2%) | $49.93 B(+20.1%) |
| Sep 2018 | - | $41.58 B(+11.5%) |
| Jun 2018 | - | $37.30 B(+7.1%) |
| Mar 2018 | - | $34.84 B(-15.3%) |
| Dec 2017 | $130.65 B(-1.5%) | $41.14 B(+2.1%) |
| Sep 2017 | - | $40.29 B(+10.7%) |
| Jun 2017 | - | $36.38 B(+1.4%) |
| Mar 2017 | - | $35.88 B(-7.9%) |
| Dec 2016 | $132.67 B(+7.4%) | $38.95 B(+1.2%) |
| Sep 2016 | - | $38.50 B(-12.2%) |
| Jun 2016 | - | $43.84 B(+6.2%) |
| Mar 2016 | - | $41.30 B(-5.7%) |
| Dec 2015 | $123.58 B(+10.4%) | $43.80 B(-2.7%) |
| Sep 2015 | - | $45.00 B(-13.0%) |
| Jun 2015 | - | $51.72 B(+4.6%) |
| Mar 2015 | - | $49.44 B(-11.1%) |
| Dec 2014 | $111.97 B(-3.4%) | $55.59 B(-2.4%) |
| Sep 2014 | - | $56.99 B(-2.2%) |
| Jun 2014 | - | $58.29 B(+0.9%) |
| Mar 2014 | - | $57.79 B(+2.8%) |
| Dec 2013 | $115.86 B(-4.2%) | $56.24 B(-5.5%) |
| Sep 2013 | - | $59.50 B(-3.1%) |
| Jun 2013 | - | $61.44 B(-5.1%) |
| Mar 2013 | - | $64.76 B(-0.1%) |
| Dec 2012 | $120.97 B(-4.9%) | $64.83 B(+13.5%) |
| Sep 2012 | - | $57.13 B(-2.8%) |
| Jun 2012 | - | $58.77 B(+7.1%) |
| Mar 2012 | - | $54.86 B(-9.8%) |
| Dec 2011 | $127.19 B(-5.5%) | $60.82 B(-3.1%) |
| Sep 2011 | - | $62.73 B(+3.7%) |
| Jun 2011 | - | $60.48 B(+3.8%) |
| Mar 2011 | - | $58.24 B(-3.7%) |
| Dec 2010 | $134.55 B(-11.1%) | $60.47 B(+11.8%) |
| Sep 2010 | - | $54.09 B(+5.8%) |
| Jun 2010 | - | $51.10 B(+2.4%) |
| Mar 2010 | - | $49.92 B(-19.1%) |
| Dec 2009 | $151.28 B(+122.2%) | $61.67 B(-16.4%) |
| Sep 2009 | - | $73.78 B(+3.1%) |
| Jun 2009 | - | $71.55 B(+31.9%) |
| Mar 2009 | - | $54.25 B(+25.9%) |
| Dec 2008 | $68.07 B(-0.5%) | $43.08 B(-10.7%) |
| Sep 2008 | - | $48.23 B(-0.9%) |
| Jun 2008 | - | $48.65 B(-4.6%) |
| Mar 2008 | - | $51.01 B(+8.9%) |
| Dec 2007 | $68.42 B(+0.8%) | $46.85 B(+12.0%) |
| Sep 2007 | - | $41.84 B(+0.5%) |
| Jun 2007 | - | $41.62 B(-1.7%) |
| Mar 2007 | - | $42.34 B(-11.2%) |
| Dec 2006 | $67.89 B | $47.66 B(+23.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $38.72 B(-5.5%) |
| Jun 2006 | - | $40.99 B(+9.6%) |
| Mar 2006 | - | $37.41 B(-20.1%) |
| Dec 2005 | $70.14 B(-16.5%) | $46.84 B(+42.9%) |
| Sep 2005 | - | $32.77 B(-2.4%) |
| Jun 2005 | - | $33.57 B(-20.7%) |
| Mar 2005 | - | $42.35 B(+8.4%) |
| Dec 2004 | $83.99 B(-2.4%) | $39.09 B(+0.1%) |
| Sep 2004 | - | $39.06 B(+6.5%) |
| Jun 2004 | - | $36.69 B(+3.7%) |
| Mar 2004 | - | $35.39 B(+15.4%) |
| Dec 2003 | $86.10 B(+299.1%) | $30.68 B(-7.2%) |
| Sep 2003 | - | $33.07 B(-4.8%) |
| Jun 2003 | - | $34.74 B(+11.7%) |
| Mar 2003 | - | $31.10 B(+25.5%) |
| Dec 2002 | $21.57 B(+8.2%) | $24.78 B(+4.7%) |
| Sep 2002 | - | $23.67 B(+5.7%) |
| Jun 2002 | - | $22.39 B(+6.8%) |
| Mar 2002 | - | $20.97 B(+9.2%) |
| Dec 2001 | $19.94 B(+22.2%) | $19.21 B(-3.9%) |
| Sep 2001 | - | $20.00 B(+2.0%) |
| Jun 2001 | - | $19.60 B(+4.8%) |
| Mar 2001 | - | $18.70 B(+8.8%) |
| Dec 2000 | $16.32 B(+8.4%) | $17.19 B(+0.1%) |
| Sep 2000 | - | $17.17 B(+8.5%) |
| Jun 2000 | - | $15.82 B(+51.6%) |
| Mar 2000 | - | $10.43 B(-36.0%) |
| Dec 1999 | $15.06 B(+79.9%) | $16.31 B(+42.0%) |
| Sep 1999 | - | $11.48 B(+3.0%) |
| Jun 1999 | - | $11.15 B(+3.7%) |
| Mar 1999 | - | $10.75 B(+8.2%) |
| Dec 1998 | $8.37 B(+10.9%) | $9.93 B(+0.6%) |
| Sep 1998 | - | $9.87 B(+19.6%) |
| Jun 1998 | - | $8.26 B(+11.5%) |
| Mar 1998 | - | $7.41 B(-0.5%) |
| Dec 1997 | $7.55 B(-7.9%) | $7.44 B(+2.8%) |
| Sep 1997 | - | $7.24 B(-1.4%) |
| Jun 1997 | - | $7.34 B(+6.0%) |
| Mar 1997 | - | $6.93 B(+7.1%) |
| Dec 1996 | $8.20 B(+24.7%) | $6.47 B(-5.0%) |
| Sep 1996 | - | $6.81 B(+4.9%) |
| Jun 1996 | - | $6.49 B(+1.3%) |
| Mar 1996 | - | $6.41 B(+4.1%) |
| Dec 1995 | $6.58 B(+23.9%) | $6.15 B(+0.3%) |
| Sep 1995 | - | $6.14 B(+2.6%) |
| Jun 1995 | - | $5.98 B(+2.7%) |
| Mar 1995 | - | $5.82 B(+0.6%) |
| Dec 1994 | $5.31 B(+15.5%) | $5.79 B(+6.7%) |
| Sep 1994 | - | $5.43 B(+4.9%) |
| Jun 1994 | - | $5.17 B(+4.6%) |
| Mar 1994 | - | $4.94 B(+4.4%) |
| Dec 1993 | $4.60 B(+9.3%) | $4.73 B(-16.9%) |
| Sep 1993 | - | $5.70 B(-0.9%) |
| Jun 1993 | - | $5.75 B(+5.7%) |
| Mar 1993 | - | $5.44 B(+0.9%) |
| Dec 1992 | $4.21 B(-12.9%) | $5.38 B(-4.5%) |
| Sep 1992 | - | $5.64 B(+12.7%) |
| Jun 1992 | - | $5.00 B(+6.3%) |
| Mar 1992 | - | $4.71 B(-2.1%) |
| Dec 1991 | $4.83 B(+4.6%) | $4.81 B(+10.2%) |
| Sep 1991 | - | $4.36 B(+0.0%) |
| Jun 1991 | - | $4.36 B(+2.5%) |
| Mar 1991 | - | $4.26 B(-4.1%) |
| Dec 1990 | $4.62 B(+20.8%) | $4.44 B(+14.2%) |
| Sep 1990 | - | $3.88 B(-2.0%) |
| Jun 1990 | - | $3.96 B(-2.1%) |
| Mar 1990 | - | $4.05 B(-10.2%) |
| Dec 1989 | $3.82 B(+7.8%) | $4.50 B(+10.0%) |
| Dec 1988 | $3.54 B(+25.5%) | $4.09 B(-0.1%) |
| Dec 1987 | $2.82 B(-0.1%) | $4.10 B(+75.3%) |
| Dec 1986 | $2.82 B(+22.5%) | $2.34 B(+8.4%) |
| Dec 1985 | $2.30 B(+43.3%) | $2.16 B(-11.5%) |
| Dec 1984 | $1.61 B | $2.44 B |
FAQ
- What is the all time high annual current assets for Pfizer?
- What is the all time high quarterly current assets for Pfizer?
What is the all time high annual current assets for Pfizer?
Pfizer all-time high annual total current assets is $64.83 B
What is the all time high quarterly current assets for Pfizer?
Pfizer all-time high quarterly total current assets is $74.01 B